Kymera Therapeutics, Inc. Common Stock (NASDAQ: KYMR) last traded at $119.80, down 1.40% on the session. The quote above updates while this page is open; the figures below are drawn from Kymera Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kymera Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker KYMR. Its market capitalisation is $9.96 billion.
Valuation measures for Kymera Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.96B |
|---|---|
| Enterprise value | $9.97B |
| Price / sales | 94.87 |
| Price / book | 6.60 |
| Beta | 0.90 |
Trailing-twelve-month figures tagged in Kymera Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $105.00M |
|---|---|
| Net income (TTM) | -$299.60M |
| EPS (TTM) | -$3.25 |
| Operating margin | -333.50% |
| Return on equity | -19.85% |
| Cash | $124.48M |
Range and volume for KYMR over the past 52 weeks.
| 52-week high | $130.05 |
|---|---|
| 52-week low | $39.84 |
| Volume | 497.3K |
| Average volume | 845.2K |
| Previous close | $121.50 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.